adalimumab-aqvh

adalimumab-aqvh (YUSIMRY) is an FDA-listed pharmaceutical active ingredient. Associated with Coherus Oncology. Route of administration: injection. Current US regulatory status: approved.

YUSIMRY is a marketed brand name for adalimumab-aqvh. Check FDA Drugs@FDA for the current US label holder and prescribing information.

adalimumab-aqvh has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.